← Back
Data updated: Mar 10, 2026
HARMAN FINOCHEM
Cardiovascular
HARMAN FINOCHEM is a generic drug manufacturer focused on Cardiovascular.
2021
Since
4
Drugs
-
Trials
40
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
ALLOPURINOL 2025-10-16
Labeling
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
METFORMIN HYDROCHLORIDE 2025-06-24
Labeling
THEOPHYLLINE 2025-06-13
Labeling
THEOPHYLLINE 2025-06-13
Labeling
ALLOPURINOL 2025-06-13
Manufacturing (CMC)
BISOPROLOL FUMARATE 2025-04-16
ALLOPURINOL 2025-04-14
METFORMIN HYDROCHLORIDE 2025-04-14
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 2021-12-03
- Latest
- 2024-07-05
- Applications
- 5